ロード中...

External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas

BACKGROUND: The majority of women with ovarian cancer are diagnosed in late stages, and the mortality rate is high. The use of biomarkers as prognostic factors may improve the treatment and clinical outcome of these patients. We performed an external validation of the potential biomarkers CLU, ITGB3...

詳細記述

保存先:
書誌詳細
主要な著者: Partheen, Karolina, Levan, Kristina, Österberg, Lovisa, Claesson, Ingela, Sundfeldt, Karin, Horvath, György
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754489/
https://ncbi.nlm.nih.gov/pubmed/19775429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-336
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!